What is NEUP's relative strength rating?

NEUP ranks at the 18th percentile over 1 month, 56th percentile over 3 months, 73th percentile over 6 months, 22th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is NEUP in?

NEUP is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data.

Is NEUP in a leading sector?

Sector RS percentile is not available for Healthcare at this snapshot. Leading sector status (threshold: Healthcare RS ≥ 70th percentile) cannot be determined until the next sector RS pipeline run.

How volatile is NEUP?

NEUP currently shows a 20-day average daily range (ADR%) of 6.6%, a 90-day beta versus the S&P 500 of 1.25. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does NEUP have a seasonal pattern?

TickerStance computes NEUP's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what NEUP has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did NEUP last report earnings?

NEUP most recently filed a 10-Q covering FY26 Q3 with the SEC on 2026-05-15. TickerStance sources earnings data from SEC EDGAR XBRL submissions and updates the fundamentals panel daily. The Pro dossier shows eight quarters of EPS and revenue trend, operating margin history, and a composite earnings-quality rank.

Neuphoria Therapeutics Inc. Common Stock (NEUP)

Free

Loading ticker…

Dossier · Pro

Neuphoria Therapeutics Inc. Common Stock · Healthcare · Pharmaceutical Products

$4.57▲+5.06%

Neutral · stance 47

TODAY'S READ · AS OF 2026-06-26

As of 2026-06-26, Neuphoria Therapeutics Inc. Common Stock (NEUP) has a 3-month relative strength percentile of 56 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 45. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 6.6%, relative volume 3.61×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

NEUPNeuphoria Therapeutics Inc. Common Stock

$4.57+0.22 ▲ +5.06%

RS 56·−79% from high·−7% vs 50D

RANGE

NEUP daily OHLC, last 60 sessions
Date	Open	High	Low	Close	Volume
2026-04-01	4.15	4.50	4.10	4.12	69042.490823
2026-04-02	4.14	4.46	4.07	4.41	62916.696682
2026-04-06	4.40	4.40	4.21	4.32	55590.412165
2026-04-07	4.29	4.60	4.25	4.60	132464.684535
2026-04-08	4.60	4.71	4.56	4.70	47840.77
2026-04-09	4.73	4.73	4.57	4.72	45151.943389
2026-04-10	4.70	4.78	4.55	4.78	60115.285476
2026-04-13	4.77	4.77	4.49	4.57	42915.065244
2026-04-14	4.55	4.71	4.44	4.71	22536.805567
2026-04-15	4.73	4.73	4.60	4.65	20401.172914
2026-04-16	4.60	4.72	4.60	4.72	11017.47483
2026-04-17	4.73	4.80	4.61	4.77	39184.724057
2026-04-20	4.65	5.04	4.65	5.03	50222.402264
2026-04-21	5.04	5.11	4.80	4.87	29539.587062
2026-04-22	4.89	5.00	4.88	4.93	33695
2026-04-23	4.84	4.99	4.80	4.91	14688.983
2026-04-24	4.87	5.06	4.81	5.04	30105.470002
2026-04-27	4.99	5.29	4.99	5.15	48615.786042
2026-04-28	5.03	5.22	5.03	5.12	12021.495372
2026-04-29	5.18	5.31	5.10	5.19	51600.241934
2026-04-30	5.20	5.37	5.19	5.27	29002.530422
2026-05-01	5.30	5.33	5.22	5.22	17981.436625
2026-05-04	5.22	5.30	5.20	5.29	10160.442256
2026-05-05	5.30	5.39	5.27	5.39	27852.819436
2026-05-06	5.45	5.45	5.31	5.38	27487.110954
2026-05-07	5.33	5.38	5.25	5.34	22220.118854
2026-05-08	5.30	5.38	5.12	5.31	36276.614173
2026-05-11	5.23	5.24	5.13	5.17	12258.346012
2026-05-12	5.20	5.20	4.91	4.93	35319.552723
2026-05-13	4.91	5.07	4.91	4.98	21190.7441
2026-05-14	4.99	5.21	4.93	5.09	21347.261094
2026-05-15	5.10	5.10	4.67	4.73	79662
2026-05-18	4.84	4.93	4.65	4.72	38171.162721
2026-05-19	4.77	4.78	4.41	4.77	174445.141258
2026-05-20	4.71	5.04	4.48	4.93	50618.748901
2026-05-21	4.93	5.18	4.82	5.12	65697.553486
2026-05-22	5.20	5.53	5.16	5.48	141922.848472
2026-05-26	5.53	5.53	5.07	5.46	23804.186383
2026-05-27	5.46	5.46	5.30	5.40	15444.206884
2026-05-28	5.43	5.48	5.22	5.36	47149.526983
2026-05-29	5.39	5.39	5.20	5.31	20300.001493
2026-06-01	5.30	5.30	5.14	5.30	38232.604892
2026-06-02	5.17	5.24	4.82	4.89	106991.051529
2026-06-03	4.81	4.87	4.69	4.70	76461.201481
2026-06-04	4.76	4.84	4.50	4.84	129464.399858
2026-06-05	4.76	4.76	4.37	4.49	82566.629333
2026-06-08	4.95	4.95	4.51	4.67	64235.476554
2026-06-09	4.64	4.89	4.52	4.66	52704.117163
2026-06-10	4.57	4.69	4.32	4.42	67047.60434
2026-06-11	4.45	4.52	4.32	4.49	75810.16666
2026-06-12	4.34	4.49	4.21	4.37	42991.74829
2026-06-15	4.55	4.55	4.23	4.29	106972.602118
2026-06-16	4.28	4.34	4.18	4.28	69603.393321
2026-06-17	4.31	4.43	4.30	4.31	15539.228623
2026-06-18	4.35	4.43	3.95	4.31	150571.267119
2026-06-22	4.33	4.53	4.21	4.44	48912.827333
2026-06-23	4.36	4.59	4.28	4.36	75387.22779
2026-06-24	4.40	4.49	4.35	4.49	32877.64871
2026-06-25	4.49	4.49	4.34	4.35	5484.46982
2026-06-26	4.41	4.64	4.23	4.57	236353.386744

2026-06-26·O 4.41H 4.64L 4.23C 4.57+0.22 ▲·VOL 236.4K

SRC · EOD·126 SESSIONS · 1D

§ Seasonality

10y · since 2024

Best monthAug on averageavg +39.70% · 100% win · n 1

Worst monthOct on averageavg -61.41% · 0% win · n 1

NEUP monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	NEUP Jan avg: 29.06% median: 29.06% win: 100% σ: 36.00% n: 2 2024-12-26 → 2026-05-29	NEUP Feb avg: 0.67% median: 0.67% win: 50% σ: 3.62% n: 2 2024-12-26 → 2026-05-29	NEUP Mar avg: 4.42% median: 4.42% win: 50% σ: 8.98% n: 2 2024-12-26 → 2026-05-29	NEUP Apr avg: 8.75% median: 8.75% win: 50% σ: 29.32% n: 2 2024-12-26 → 2026-05-29	NEUP May avg: 15.91% median: 15.91% win: 100% σ: 21.43% n: 2 2024-12-26 → 2026-05-29	NEUP Jun avg: 6.85% median: 6.85% win: 100% σ: 0.00% n: 1 2024-12-26 → 2026-05-29 (current)	NEUP Jul avg: 14.22% median: 14.22% win: 100% σ: 0.00% n: 1 2024-12-26 → 2026-05-29	NEUP Aug avg: 39.70% median: 39.70% win: 100% σ: 0.00% n: 1 2024-12-26 → 2026-05-29	NEUP Sep avg: 4.06% median: 4.06% win: 100% σ: 0.00% n: 1 2024-12-26 → 2026-05-29	NEUP Oct avg: -61.41% median: -61.41% win: 0% σ: 0.00% n: 1 2024-12-26 → 2026-05-29	NEUP Nov avg: -0.66% median: -0.66% win: 0% σ: 0.00% n: 1 2024-12-26 → 2026-05-29	NEUP Dec avg: -31.21% median: -31.21% win: 0% σ: 24.12% n: 2 2024-12-26 → 2026-05-29

Fundamentals · NEUP

Does the business back the chart?

SEC EDGAR · last filing 10-Q · FY26 Q3 · period end 2026-03-31

—

Fundamentals Growth Rank

How does growth rank vs. the universe?

Insufficient history: EPS 8Q, revenue 2Q (6Q minimum)

View fundamental leadership map

Earnings

Is earnings accelerating?

Diluted EPS, last 8 quarters. Positive EPS uses YoY change.

Swung to loss

−$2.83—

24 Q1

−$0.62—

24 Q3

−$1.79—

Evidence · 1 of 3

Receipts behind the read

1 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

LDR

—

StageWeinstein stage analysis

Stage 1 · Basing

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

A/D rating

FAQ

Frequently asked questions

What is NEUP's relative strength rating?: NEUP ranks at the 18th percentile over 1 month, 56th percentile over 3 months, 73th percentile over 6 months, 22th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is NEUP in?: NEUP is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data.
Is NEUP in a leading sector?: Sector RS percentile is not available for Healthcare at this snapshot. Leading sector status (threshold: Healthcare RS ≥ 70th percentile) cannot be determined until the next sector RS pipeline run.
How volatile is NEUP?: NEUP currently shows a 20-day average daily range (ADR%) of 6.6%, a 90-day beta versus the S&P 500 of 1.25. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does NEUP have a seasonal pattern?: TickerStance computes NEUP's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what NEUP has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.
When did NEUP last report earnings?: NEUP most recently filed a 10-Q covering FY26 Q3 with the SEC on 2026-05-15. TickerStance sources earnings data from SEC EDGAR XBRL submissions and updates the fundamentals panel daily. The Pro dossier shows eight quarters of EPS and revenue trend, operating margin history, and a composite earnings-quality rank.

§ Seasonality

Does the business back the chart?

Is earnings accelerating?

Receipts behind the read

Is it leading?

Who's accumulating?

NEUP is not confirmed as a leader.

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?

How much does it move?

Sector context

Who else is leading?

Healthcare

Same industry, closest relative strength

Market backdrop

Is the crowd watching?

Company snapshot

Frequently asked questions

§ Seasonality

Neuphoria Therapeutics Inc. Common Stock (NEUP) — Stance & relative strength

Does the business back the chart?

Is earnings accelerating?

Receipts behind the read

Is it leading?

Who's accumulating?

NEUP is not confirmed as a leader.

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?

How much does it move?

Sector context

Who else is leading?

Healthcare

Same industry, closest relative strength

Market backdrop

Is the crowd watching?

Company snapshot

Frequently asked questions